HAE (STOCKS)
Haemonetics Corporation
$57.640000
+0.140000 (+0.24%)
Prev close: $57.500000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christopher A. Simon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,678.15M
- Employees
- 3,023
- P/E (TTM)
- 15.84
- P/B (TTM)
- 2.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$1.31 | $1.26 | +0.0473 | +3.75% |
|
Sep 2025 (Q2)
|
$1.27 | $1.12 | +0.1487 | +13.26% |
|
Jun 2025 (Q1)
|
$1.10 | $1.03 | +0.0738 | +7.19% |
|
Mar 2025 (Q4)
|
$1.24 | $1.23 | +0.0076 | +0.62% |
Financial Statements
| Revenues | $1.32B |
| Benefits Costs and Expenses | $1.09B |
| Cost Of Revenue | $535.85M |
| Costs And Expenses | $1.09B |
| Gross Profit | $782.42M |
| Operating Expenses | $531.33M |
| Selling, General, and Administrative Expenses | $436.62M |
| Depreciation and Amortization | $112.61M |
| Research and Development | $63.63M |
| Operating Income/Loss | $251.09M |
| Income/Loss From Continuing Operations After Tax | $175.44M |
| Income/Loss From Continuing Operations Before Tax | $227.17M |
| Income Tax Expense/Benefit | $51.73M |
| Income Tax Expense/Benefit, Deferred | -$3.05M |
| Net Income/Loss | $175.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $175.44M |
| Net Income/Loss Available To Common Stockholders, Basic | $175.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.64 |
| Diluted Earnings Per Share | $3.63 |
| Basic Average Shares | 47,118,000 |
| Diluted Average Shares | 47,250,000 |
| Assets | $2.49B |
| Current Assets | $943.67M |
| Inventory | $321.19M |
| Other Current Assets | $622.49M |
| Noncurrent Assets | $1.55B |
| Fixed Assets | $297.23M |
| Intangible Assets | $419.73M |
| Other Non-current Assets | $830.25M |
| Liabilities | $1.58B |
| Current Liabilities | $539.87M |
| Accounts Payable | $48.69M |
| Wages | $52.10M |
| Other Current Liabilities | $439.08M |
| Noncurrent Liabilities | $1.04B |
| Long-term Debt | $1.22B |
| Equity | $911.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $911.45M |
| Liabilities And Equity | $2.49B |
| Net Cash Flow From Operating Activities | $338.84M |
| Net Cash Flow From Operating Activities, Continuing | $338.84M |
| Net Cash Flow From Investing Activities | -$74.89M |
| Net Cash Flow From Investing Activities, Continuing | -$74.89M |
| Net Cash Flow From Financing Activities | -$228.41M |
| Net Cash Flow From Financing Activities, Continuing | -$228.41M |
| Exchange Gains/Losses | $6.99M |
| Net Cash Flow | $42.52M |
| Net Cash Flow, Continuing | $35.53M |
| Comprehensive Income/Loss | $196.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $196.33M |
| Other Comprehensive Income/Loss | $20.89M |